pyrroles has been researched along with Schizophrenia in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 6 (20.69) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Aricioglu, F; Bekci, H; Cumaoglu, A; Unal, G; Yerer, MB | 1 |
| Aricioglu, F; Sirvanci, S; Unal, G | 1 |
| Mulder, RT; Rucklidge, JJ; Sarris, J; Warren, B | 1 |
| Meltzer, HY; Miyauchi, M; Neugebauer, NM | 1 |
| Dutta, S; Florian, H; Gertsik, L; Haig, G; Locke, C; Othman, AA | 1 |
| Bain, E; Baker, J; Haig, GM; Lenz, RA; Othman, AA; Robieson, W | 1 |
| Conn, PJ; Daniels, JS; Dickerson, JW; Ghoshal, A; Jalan-Sakrikar, N; Jones, CK; Lamsal, A; Lindsley, CW; Melancon, BJ; Morrison, RD; Niswender, CM; Noetzel, MJ; Poslusney, MS; Rook, JM; Roop, GN; Stauffer, SR; Wood, MR; Xiang, Z | 1 |
| Corcoba, A; Cuenod, M; Do, KQ; Duarte, JM; Gruetter, R; Monin, A; Steullet, P; Van de Looij, Y | 1 |
| Huang, XF; Kapsa, RM; Stewart, EM; Wallace, GG; Wu, Z | 1 |
| Brandon, NJ; Hinchliffe, RM; Huszar, SL; Hutson, PH; Jacobson, MA; Jones, B; Kandebo, M; McNaughton, CH; Mullins, CM; Pascarella, DM; Sachs, N; Smith, SM; Sparey, T; Surles, NO; Uslaner, JM; Venkatraman, S; Yao, L; Young, MB | 1 |
| Williams, M | 1 |
| Boers, GH; The, GK; van de Kerkhof, R; van der Meer, JW | 1 |
| Abeywickrema, P; Almond, S; Brandon, N; Byrne, N; Campbell, A; Hutson, PH; Jacobson, M; Jones, B; Munshi, S; Pascarella, D; Pike, A; Prasad, GS; Sachs, N; Sakatis, M; Sardana, V; Sparey, T; Venkatraman, S; Young, MB | 1 |
| Dimitri, E; Landry, P; Légaré, N; Tessier, S | 1 |
| Kaufman, J; Renz, RH; Smith, S; Sohler, A | 1 |
| Gorchein, A | 1 |
| Bristow, LJ; Kramer, MS; Kulagowski, J; Patel, S; Ragan, CI; Seabrook, GR | 1 |
| Chari, S; Deth, RC; DuRand, CJ; Kotb, M; Kramer, ML; Liu, D; Nagata, M; Ouellette, D; Sharma, A; Shim, S; Tan, W; Wick, PF | 1 |
| Gorchein, A; Rogers, AT | 1 |
| Duhan, HA; Gendler, PL; Rapoport, H | 1 |
| Cruz, R; Vogel, WH | 1 |
| Irvine, DG | 1 |
| Ellman, GL; Jacobson, SJ; Rapoport, H | 1 |
| Sohler, A | 1 |
| Heleniak, EP; Lamola, SW | 1 |
| Ban, TA | 1 |
| Durkó, I; Huszák, I; Karsai, K | 1 |
| Krischer, K; Pfeiffer, CC | 1 |
| Grant, FW | 1 |
2 review(s) available for pyrroles and Schizophrenia
| Article | Year |
|---|---|
Pyroluria: Fact or Fiction?
Topics: Adult; Child; Female; Humans; Male; Porphyrias; Pyrroles; Schizophrenia; Vitamin B 6; Vitamin B 6 Deficiency; Zinc | 2021 |
Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
Topics: Animals; Antipsychotic Agents; Biological Availability; Clinical Trials as Topic; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Pyridines; Pyrroles; Receptors, Dopamine D4; Rodentia; Schizophrenia | 1997 |
3 trial(s) available for pyrroles and Schizophrenia
| Article | Year |
|---|---|
The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.
Topics: Adult; Area Under Curve; Double-Blind Method; Female; Histamine H3 Antagonists; Humans; Male; Middle Aged; Pyridazines; Pyrroles; Schizophrenia | 2014 |
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.
Topics: Adult; Cognition Disorders; Double-Blind Method; Female; Histamine H3 Antagonists; Humans; Male; Middle Aged; Pyridazines; Pyrroles; Schizophrenia; Treatment Failure | 2014 |
Negative findings with nicotinic acid in the treatment of schizophrenias.
Topics: Adrenochrome; Bufotenin; Dimethoxyphenylethylamine; Drug Therapy, Combination; Female; Humans; Male; Methionine; Methylation; Nicotinic Acids; Placebos; Pyridoxine; Pyrroles; Schizophrenia | 1974 |
24 other study(ies) available for pyrroles and Schizophrenia
| Article | Year |
|---|---|
Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Avoidance Learning; Clozapine; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Dizocilpine Maleate; Glycogen Synthase Kinase 3 beta; Isoxazoles; Male; Phenylurea Compounds; Prefrontal Cortex; Proto-Oncogene Proteins c-akt; Pyridazines; Pyrroles; Rats; Rats, Wistar; Schizophrenia; Signal Transduction; Social Interaction; Treatment Outcome | 2020 |
α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Behavior, Animal; Cognitive Dysfunction; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hippocampus; Isoxazoles; Male; Nicotinic Agonists; Phenylurea Compounds; Pyridazines; Pyrroles; Rats; Rats, Wistar; Recognition, Psychology; Schizophrenia | 2021 |
Dopamine D
Topics: Animals; Antipsychotic Agents; Benzamides; Clozapine; Cognitive Dysfunction; Female; Lurasidone Hydrochloride; Phencyclidine; Piperazines; Pyridines; Pyrroles; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D4; Schizophrenia; Serotonin 5-HT1 Receptor Agonists | 2017 |
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.
Topics: Animals; Antipsychotic Agents; Cognition; Disease Models, Animal; Long-Term Synaptic Depression; Male; Mice, Inbred C57BL; Mice, Knockout; Patch-Clamp Techniques; Phencyclidine; Pyridines; Pyrroles; Receptor, Muscarinic M1; Schizophrenia; Schizophrenic Psychology; Social Behavior | 2016 |
Glutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for Schizophrenia.
Topics: Animals; Brain; Diffusion Tensor Imaging; Disease Models, Animal; Glutamate-Cysteine Ligase; Glutathione; Male; Mice, Knockout; Organ Size; Pyrroles; Schizophrenia; Tissue Culture Techniques; White Matter | 2015 |
Use of conducting polymers to facilitate neurite branching in schizophrenia-related neuronal development.
Topics: Cell Line; Gene Knockout Techniques; Humans; Neuregulin-1; Neurons; Polymers; Pyrroles; Schizophrenia; Tissue Scaffolds | 2016 |
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Topics: Aged; Animals; D-Amino-Acid Oxidase; Dizocilpine Maleate; Habituation, Psychophysiologic; Humans; Male; Models, Molecular; Pyrroles; Rats; Rats, Wistar; Recognition, Psychology; Schizophrenia; Serine; Thiophenes | 2009 |
Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Topics: Animals; Antipsychotic Agents; D-Amino-Acid Oxidase; Enzyme Activators; Genome, Human; Humans; Isoxazoles; Pyrazoles; Pyrroles; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Thiophenes | 2009 |
[Hemopyrrollactamuria (HPU); from spots to pseudo-disease].
Topics: Humans; Metabolic Diseases; Porphyrias; Pyrroles; Schizophrenia | 2003 |
The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Topics: Animals; Carboxylic Acids; Combinatorial Chemistry Techniques; Crystallography, X-Ray; D-Amino-Acid Oxidase; Enzyme Inhibitors; Molecular Conformation; Molecular Structure; Pyrroles; Rats; Schizophrenia; Serine | 2008 |
Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Atorvastatin; Cholesterol; Clozapine; Female; Fenofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Psychotic Disorders; Pyrroles; Retrospective Studies; Schizophrenia; Treatment Outcome; Triglycerides | 2008 |
Significance of hydroxyskatole and mauve factor excretion in schizophrenia.
Topics: Adult; Alcoholism; Chromatography, Thin Layer; Chronic Disease; Epilepsy; Furans; Humans; Indoles; Male; Middle Aged; Pyrroles; Schizophrenia | 1967 |
Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one ('mauve factor') is not causally related to schizophrenia or to acute intermittent porphyria.
Topics: Acute Disease; Adult; Chromatography, Gas; Female; Humans; Porphyrias; Pyrroles; Schizophrenia | 1980 |
D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
Topics: Amino Acid Sequence; Aminopyridines; Animals; Benzazepines; Binding Sites; Carbon Radioisotopes; CHO Cells; Clozapine; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Formates; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Methionine; Mutagenesis, Site-Directed; Neuroblastoma; Phospholipids; Phosphorylation; Piperidines; Psychotic Disorders; Pyridines; Pyrroles; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; S-Adenosylmethionine; Salicylamides; Schizophrenia; Transfection; Tumor Cells, Cultured | 1999 |
The 'mauve factor' of schizophrenia and porphyria, 5-hydroxyhaemopyrrole lactam, has low pharmacological potency on guinea-pig ileum.
Topics: Animals; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Humans; Ileum; Muscle Contraction; Porphyrias; Pyrroles; Rats; Schizophrenia | 1979 |
Hemopyrrole and kryptopyrrole are absent from the urine of schizophrenics and normal persons.
Topics: Chromatography, Gas; Humans; Mass Spectrometry; Methods; Porphyrias; Pyrroles; Schizophrenia | 1978 |
Pyroluria: a poor marker in chronic schizophrenia.
Topics: Adult; Chronic Disease; Female; Humans; Male; Middle Aged; Pyrroles; Schizophrenia; Vitamin B 6 Deficiency; Zinc | 1978 |
Hydroxy-hemopyrrolenone, not kryptopyrrole, in the urine of schizophrenics and porphyrics.
Topics: Humans; Isomerism; Porphyrias; Pyrroles; Schizophrenia | 1978 |
The nonoccurrence of hemo- and kryptopyrrole in urine of schizophrenics.
Topics: Chromatography, Gas; Humans; Mass Spectrometry; Pyrroles; Schizophrenia | 1975 |
Letter: Urinary kryptopyrrole.
Topics: Humans; Pyrroles; Schizophrenia | 1975 |
A new prostaglandin disturbance syndrome in schizophrenia: delta-6-pyroluria.
Topics: Alprostadil; Aspartate Aminotransferases; Fatty Acid Desaturases; Fatty Acids, Essential; Humans; Insulin; Linoleic Acid; Linoleic Acids; Linoleoyl-CoA Desaturase; Mutation; Prostaglandins; Pyrroles; Schizophrenia; Syndrome | 1986 |
Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
Topics: Chromatography; Depression; Epilepsy; Humans; Mass Screening; Paranoid Disorders; Periodicity; Porphyrins; Psychotic Disorders; Pyrroles; Schizophrenia; Tryptophan | 1972 |
Biochemical relationship between kryptopyrrole (mauve factor and trans-3-methyl-2-hexenoic acid (schizophrenia odor).
Topics: Caproates; Carboxylic Acids; Decarboxylation; Humans; Pyrroles; Schizophrenia | 1973 |
Comments on a proposed mechanism of formation of the "schizophrenic odor factor".
Topics: Amines; Biotransformation; Caproates; Deamination; Fatty Acids, Unsaturated; Humans; Odorants; Pyrroles; Schizophrenia; Sweat; Transaminases; Vinyl Compounds | 1973 |